The mdm2 gene encodes a family of proteins, a subset of which bind p53 and negatively regulate its function as a transcription factor. We now show that an anti-mdm-2 monoclonal antibody, 2A10, recognises a protein present in rabbit reticulocyte lysate which binds murine p53 translated in vitro. Deletion of p53 residues 10 ± 35, which encompass the mdm-2 binding site, abolished binding of this 2A10-reactive protein. Binding was also dependent upon p53 protein conformation and may require nascent p53 polypeptide since binding was lost following conformational shifting of the temperaturesensitive mutant A135V. Previous studies have shown that mdm-2-p53 complexes fail to exhibit detectable sequence-speci®c DNA binding. However, our present results demonstrate that p53 in complex with an mdm-2-related protein in vitro retained sequence-speci®c DNA binding capacity. Non-transformed (but not transformed) 3T3 cells were also found to express a similar 2A10-reactive protein, detectable by gel shift analysis of cellular p53 in complex with a speci®c DNA target. Mdm-2 in rabbit reticulocyte lysate and in normal, nontransformed 3T3 cells may represent constitutively expressed protein. Our results raise the possibility that constitutive mdm-2 may enhance and/or suppress functions of p53 as yet unidenti®ed.
Introduction
Mdm-2 can function as a negative regulator of p53, able to suppress p53-mediated transcriptional activation of target genes (Oliner et al., 1993; Chen et al., 1994; Haines et al., 1994; reviewed in Gottlieb and Oren, 1996) . Interaction between p53 and mdm-2 involves the amino terminus of each protein. The amino terminus of p53 is also essential for interaction with transcription machinery of the cell, including TBP and TAFs, and it is likely that mdm-2 inhibits p53 function by blocking association with accessory transcription proteins (Oliner et al., 1993; Perry et al., 1993; Picksley et al., 1994) . Interaction with mdm-2 also inhibits speci®c DNA binding by p53 and transrepression by p53 . Transcription of mdm-2 is up-regulated by p53 and inhibition of p53 by mdm-2 completes a negative feed-back loop (Momand et al., 1992; Barak et al., 1993; Perry et al., 1993; Wu et al., 1993) . Overexpression of mdm2 is linked with increased tumorogenic potential of aected cells and mdm2 ampli®cation is observed in human tumours, including sarcomas, leukaemias and high grade gliomas (Oliner et al., 1992; Bueso-Ramos et al., 1995; Gottlieb and Oren, 1996 and references therein). Recent reports indicate that the repertoire of mdm-2 functions may be extensive. For example, mdm-2 and mdm-2-p53 complexes have been shown to bind ribosomal L5 protein-5S RNA, thus linking mdm-2-p53 interaction with ribosome biogenesis and/or translational control in the cell (Marechal et al., 1994) . Mdm-2 also favours cell proliferation by positive stimulation of S-phase transcription factors E2F1/DP1 (Martin et al., 1995) and by negative regulation of the tumour suppressor pRB (Xiao et al., 1995) .
The mdm-2 gene was originally described as an ampli®ed DNA sequence on murine double minute chromosomes in a spontaneously transformed 3T3 cell line (3T3DM; Cahilly-Snyder et al., 1987) . The gene encodes a protein of 489 residues and apparent molecular weight of 90 kDa. Lower molecular weight forms of mdm-2, such as p76, p74 and p57, are probably generated by alternative splicing and/or posttransational modi®cation. Only some bind p53 (Haines et al., 1994; Olson et al., 1993; see Table 1 ). The dierent forms of mdm-2 have been characterised by their reactivities with monoclonal antibodies Olson et al., 1993;  Table 1 ). The 2A10 monoclonal antibody has the highest anity for mdm-2 and is able to detect low levels of mdm-2 and coimmunoprecipitates mdm2-p53 and the ribosomal L5 protein in mdm2-p53 complexes (Marechal et al., 1994) .
In the present study we have employed monoclonal antibodies against mdm-2 (kindly made available by Arnold Levine, Princeton University, USA) to screen for mdm-2 related proteins associated with murine p53-DNA complexes, using p53-CON as speci®c DNA target for p53 binding (Funk et al., 1992) . Wild type and mutant p53 proteins were translated in vitro in rabbit reticulocyte lysate and p53-DNA complexes analysed by gel shift in non-denaturing gel electrophoresis. The 2A10 monoclonal antibody was found to detect p53-DNA complexes and was also able to co-immunoprecipitate p53 in the absence of DNA. These results indicate that reticulocyte lysate contains an mdm-2 related protein which is reactive with 2A10 and which binds p53. Binding was selective for wild type p53 protein conformation and required residues 10 ± 34, which encompass the known mdm-2 binding site. Similar results were observed for endogenous p53 from 3T3 cells, suggesting that this newly described mdm-2 related protein may be expressed constitutively in non-transformed murine ®broblasts.
Results

2A10 detects p53-DNA complexes
The ability of anti-mdm-2 monoclonal antibodies (Table 1) to detect p53-DNA complexes was tested by gel shift analyses, using wild type murine p53 translated in vitro and the consensus DNA target (p53-CON; Funk et al., 1992) . All gel shifts were carried out in the presence of PAb421, unless otherwise stated (Materials and methods). The 3G5 monoclonal antibody only detects free mdm-2 and, as expected, failed to detect p53 (not shown) or p53-DNA complexes (Figure 1a ) Monoclonals 4B2, 2A9 and 4B11 also failed to detect p53-DNA complexes, as did an antibody directed against the TATA-box binding protein TBP (Figure 1a) . However, 2A10 consistently gave a clear and complete shift of the p53-DNA complexes (Figure 1a ). 2A10 also coimmunoprecipitated freshly translated wild type p53 ( Figure 1b ) but failed to co-immunoprecipitate the temperature-sensitive mutant, p53 A135V, when expressed in the mutant conformation (246/1620-negative, 240-positive; results not shown). Control gel shift experiments indicated that the 2A10 monoclonal antibody does not interact directly with the radiolabelled pCON DNA following incubation in rabbit reticulocyte lysate (in the absence of in vitro translated p53). These controls also included reticulocyte lysate containing mutant p53, with negative results for pCON gel shift similar to those observed in Figure 3 Even though 2A10 is thought to be speci®c for mdm-2, these results prompted us to ask if 2A10 can also bind p53 directly. Wild type p53 was fractionated on a TSK3000 column to give monomeric and oligomeric fractions (Materials and methods). We reasoned that, if 2A10 recognises an epitope on p53 it should detect the monomeric p53 protein. However, monomeric p53 was not reactive with 2A10 (fractions 15/16; Figure 1c) , and the 2A10 monoclonal antibody only immunoprecipitated oligomeric p53 complexes (fractions 8/9; Figure 1c ). Both monomeric and oligomeric p53 fractions retained the wild type conformation, as indicated by reactivity with the conformation-dependent monoclonal antibody PAb246 ( Figure 1c ). This result is consistent with the notion that oligomers of wild type p53 contain additional protein(s) following translation in vitro, the additional proteins being derived from the rabbit reticulocyte lysate. A similar phenomonen has been observed for mutant p53, which is recognised and bound by hsp70 present in the reticulocyte lysate used for translation (Hainaut and Milner, 1992) . Reactivity with the 2A10 antibody indicates an mdm2-related protein. If binding involves the mdm2-binding site on p53 this could explain our inability to obtain p53 complexes with in vitro translated mdm-2 (results not shown).
Deletion of the mdm-2 binding site abolishes p53 detection by 2A10 Zauberman et al. (1993) have found that p53-mdm2 complexes fail to exhibit sequence-speci®c DNA binding to a p53 target site derived from a murine GLN-LTR element. Although these authors were careful to point out that mdm2-p53 complexes may bind eciently to other DNA targets, inhibition of p53 speci®c DNA binding by mdm2 is an attractive model for the negative regulation of p53 function by mdm2. The detection of an mdm2-related protein in p53-DNA complexes was therefore unexpected (Figure 1a ), and we next attempted to con®rm the identity of the 2A10-reactive protein (i) by immunoblotting with anti-mdm2 monclonal antibodies (4B2 and 4B11), and (ii) by deletion of the known mdm-2 binding domain on p53. The immunoblots were negative, probably due to protein levels below the threshold for detection, since in vitro translated p53 is also undetectable by Figure 2a) . The 2A10 gel shift of p53-DNA complexes was also lost (Figure 2b) . Importantly, the deletion mutant of p53 retained the wild type phenotype (246-positive/240-negative; Figure 2a ) and had a normal oligomerisation pro®le (not shown). The above results indicate (i) that wild type p53 associates with an mdm-2 protein when translated in vitro and (ii) that this mdm-2 protein is retained in complex with p53 following binding to a speci®c DNA target.
Binding of p53 to the 2A10-reactive protein requires nascent p53
When wild type murine p53 was translated in wheat germ extract it was non-reactive with 2A10 and did not acquire 2A10 reactivity even when subsequently incubated with rabbit reticulocyte lysate (results not shown). This raised the possibility that active synthesis of p53 protein is required for interaction with the mdm2-related protein from reticulocyte lysate. In order to investigate this further we used the temperaturesensitive mutant A135V. When translated in vitro this mutant adopts the wild type conformation at 308C (246-positive/240-negative) and the mutant form at 378C (246-negative/240-positive; Milner and Medcalf, 1990) . Moreover, post-translational changes in conformation are induced by simple temperature shift and partial refolding into the 246-positive conformation is enhanced by ATP and redox factors present in fresh rabbit reticulocyte lysate (Milner and Medcalf, 1990; Hainaut and Milner, 1993) . Following translation at 308C p53-A135V was competent for speci®c DNA binding and the p53-DNA complexes were partially shifted by 2A10 antibody (Figure 3a) . This partial shift is in contrast to the complete 2A10 shift routinely obtained with wild type p53-DNA complexes (see Figure 1a ) and may re¯ect reduced conformational stability of the temperature-sensitive mutant. When incubated at 378C for 5 min the mutant protein changed to the 246-negative/240-positive p53 conformation (not shown) and lost speci®c DNA binding capacity (Figure 3b ). Temperature reversion back to 308C resulted in partial recovery of speci®c DNA binding. However, the resulting p53-DNA complexes were non-reactive with 2A10 (Figure 3c) .
These results indicate that interaction between p53 and the mdm-2-related protein is disrupted when p53-A135V switches from`wild type' to mutant conformation. Refolding of full length p53 back to the`wild type' conformation failed to restore mdm-2-p53 complexes (as measured by gel shift with 2A10, Figure Figure 3 2A10 detection of p53-DNA complexes with the temperature-sensitive A135V mutant before and after temperature-shifts. Radiolabelled p53A135V was translated at 308C and an aliquot bound to p53-CON DNA (a). Residual p53 was shifted to 378C for 5 min (in the presence of anisomycin to block further protein synthesis) and a second aliquot incubated with p53-CON DNA (i.e. 308C to 378C; b). The remaining aliquot was reversed again to 308C for a further 30 min and tested for DNA binding (i.e. 308C to 378C to 308C; c). All gel shifts were carried out in the presence of PAb421, with and without 2A10 as indicated. Lower arrow=p53-DNA complexes in the presence of PAb421; upper arrow=p53-DNA complexes super-shifted with 2A10 antibody p53-DNA complexes contain an mdm2-related protein AR Hall and J Milner 3c). It is therefore possible that interaction with the 2A10-reactive protein requires nascent or newly translated p53 polypeptide. In this context it is interesting to note that ribonucleoprotein complexes containing p53 and mdm-2 may be implicated in translation regulation in the cell (Marechal et al., 1994) .
2A10 detects p53 from non-transformed murine ®broblasts but not from transformed ®broblasts
In order to ask if endogenous mdm-2-p53 complexes are detectable in normal cells we performed gel shift assays with p53 from non-transformed 3T3 ®broblasts. In this system we routinely observe two bands of cellular p53-DNA complexes in the presence of PAb421, and both bands are supershifted into a single band with PAb248 (Figure 4) . The 2A10 monoclonal antibody partially supershifted the upper p53-DNA band, indicating that a signi®cant proportion of endogenous p53 from 3T3 cells is complexed with an mdm-2 related protein and that the endogenous mdm-2-p53 complexes are able to bind a speci®c DNA target in vitro. This mdm-2 protein appears to be constitutively expressed (see Discussion). P53 from the transformed T3T3 cell line was also examined. These cells express genotypically mutant p53 in the`wild type' conformation (Milner et al., 1991; Zerrahn et al., 1992) . The p53 from T3T3 cells was competent for speci®c DNA binding in vitro (Figure 4 ). However no evidence of 2A10 supershifting was detectable for p53-DNA complexes derived from transformed T3T3 cells (Figure 4) .
Discussion
Unravelling the functions of mdm-2 is complicated both by the existence of multiple mdm-2 proteins with dierent properties, and by dierential transcriptional regulation involving at least two promoters. An upstream promoter (P1) is responsible for the constitutive expression of mdm-2 and is independent of p53. A second internal promoter (P2) is selectively activated by p53 and may give rise to distinct mdm-2 protein(s) (Barak et al., 1994; Zauberman et al., 1995) . For the purposes of this discussion constitutive and inducible mdm-2 will be referred to as mdm-2 c and mdm-2 i respectively. The postulated p53/mdm-2 negative feed-back loop (see Introduction) presumably involves mdm-2 i , up-regulated by activated p53. Mdm-2 i is able to complex with p53 and inhibit speci®c DNA binding, p53 transactivation and transrepression functions (see Introduction).
In the present study we describe indirect evidence for an mdm-2 protein, present in rabbit reticulocyte lysate and expressed in non-transformed 3T3 cells. Its level appeared to be very low and it is possible that this mdm2 protein may represent mdm2 c . It was initially detected by virtue of its ability to complex with in vitro translated p53, resulting in co-immunoprecipitation of the radiolabelled p53 protein with the 2A10 anti-mdm-2 monoclonal antibody (Figure 1 ). This antibody is speci®c for mdm-2 and shows high anity binding for a conformation-dependent epitope conserved between murine and human mdm-2 Marechal et al., 1994) . Deletion of the mdm-2 binding site from p53 abolished detection by 2A10 (Figure 2) , re-enforcing its identi®cation as an mdm2-related protein. The monoclonal antibody 4B2 detects an epitope overlapping with the p53-binding domain of p53 and this would explain its inability to detect mdm-2-p53 complexes (Figure 1a) . Lack of reactivity with 4B11, directed against the carboxyl terminus of mdm-2 suggests that C-terminal truncated forms of mdm2 c may exist, possibly similar to p57, which also lacks the carboxyl terminus of mdm-2 but is co-immunoprecipitated with p53 . Leng et al. (1995) have positioned the p53-binding domain of mdm-2 within amino acids 14 to 154 of the mdm-2 protein.
Our results indicate a novel mdm-2 protein, possibly mdm2 c , with properties distinct from mdm-2 i in that it not only fails to block speci®c DNA binding by p53 but is retained in p53-DNA complexes (Results section). This suggests that mdm-2 c may enhance and/ or suppress certain function(s) of p53 as yet unde®ned. The variant forms of mdm-2 have been shown to associate with dierent nuclear structures (Maxwell, 1994) suggesting distinct functions for individual mdm-2 proteins. This would be consistent with the observed diversity of mdm-2 protein-protein interactions and their eects on target protein function (see Introduc- lethality, indicating that the regulatory interaction between mdm2 and p53 proteins is vital for early embryonic development (Montes de Oca Luna et al., 1995) . This may involve mdm2 c and further studies are required to determine the function(s) of constitutively expressed mdm2 proteins.
Materials and methods
In vitro transcription and translation
Murine p53 was transcribed and translated in vitro as described previously (Milner and Medcalf, 1990) . Plasmids pSP65p53 and pSPp53Val135 encode wild type and the temperature-sensitive A135V mutant respectively. Each was linearised with HindIII and transcribed using SP6 polymerase. Full length murine mdm2 was encoded by the plasmid pGem1mdm2B (Barak et al., 1994) Milner and Medcalf, 1990 ).
Immunoprecipitation and size fractionation
Radiolabelled proteins were diluted 1 in 100 in buer containing (10 mM Tris-HCl pH7.5; 140 mM NaCl; 0.5% NP40) and immunoprecipitated as described in Milner and Medcalf (1990) . Monoclonal antibodies against p53 were PAb421, PAb246, PAb240, and PAb248 (see Milner and Medcalf, 1990 for details); monoclonal antibodies to mdm2 were 2A9, 2A10, 3G5, 4B2 and 4B11 Olson et al., 1993, see Table 1 ). The monoclonal antibody 4C8 is directed against TBP protein. Negative control immunoprecipitations employed either PAb416 or PAb419, both detect the large T antigen of simian virus 40. Immune complexes were harvested and proteins resolved by SDS ± PAGE; radiolabelled proteins were visualised by autoradiography. Size fractionation of proteins was by fast performance liquid chromatography (FPLC), using a TSK3000 column, as detailed in Hainaut et al. (1994) .
Gel shifts of p53-DNA complexes
In vitro translated p53 was incubated with 5 ng 32 P-end labelled p53CON (5'-GGACATGCCCGGGCATGTCC-3'; Funk et al., 1992) in DNA binding buer (20 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.1% NP40 plus 10% glycerol, 5 mM DTT, 100 ng salmon sperm DNA) in the presence of PAb421 to stabilise p53-DNA complexes (Funk et al., 1992) . Binding was for 30 min at room temperature. Complexes were loaded on a 4% PAGE in TBE (1 mM EDTA) and electrophoresed for 4 h at 122 V with water cooling (8 ± 128C). Gels were exposed for autoradiography at 7708C using Fuji RX X-ray ®lm; aluminium foil was placed between the gel and ®lm to cut out the signal from the [
35 S]methionine (Milner et al., 1991) .
Preparation of cellular p53 and DNA binding
Balb/c mouse 3T3 and T3T3 cells (Milner et al., 1991 Zerrahn et al., 1992) were washed in RPMI and exposed to mitomycin C (10 mg ml -1 ; Sigma) for 2 h to stabilise p53: under these conditions p53 levels begin to rise between 2 to 4 h, reaching a maximum at 16 ± 24 h (Fritsche et al., 1993) . Cells were washed in RPMI and scraped lysed in RIPA buer (10 mM Tris-Cl pH 8, 150 mM NaCl, 1 mM EDTA, 1% NP40, 0.1% SDS, 1 mM PMSF, 30 mg/ml aprotinin, 10 mg/ml Leupeptin and 10 mg/ ml pepstatin) and centrifuged at 15 000 r.p.m. for 20 min at 48C in F-28 rotor (Sorvall). 100 ml of extract was assayed for binding to p53CON by EMSA, in the presence of 100 ng salmon sperm DNA and 30 ml PAb421 hybridoma supernatant. Salt concentration is an important factor in p53 DNA binding (Butcher et al., 1994) and the cell extract was corrected to 150 mM NaCl.
